Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2020 Nov 28;11(12):1428.
doi: 10.3390/genes11121428.

Susceptibility to Heart Defects in Down Syndrome Is Associated with Single Nucleotide Polymorphisms in HAS 21 Interferon Receptor Cluster and VEGFA Genes

Carmela Rita Balistreri  1 , Claudia Leonarda Ammoscato  2 , Letizia Scola  1 , Tiziana Fragapane  3 , Rosa Maria Giarratana  1 , Domenico Lio  1 , Maria Piccione  2
Affiliations
Clinical Trial

Susceptibility to Heart Defects in Down Syndrome Is Associated with Single Nucleotide Polymorphisms in HAS 21 Interferon Receptor Cluster and VEGFA Genes

Carmela Rita Balistreri et al. Genes (Basel). .

Abstract

Background: Congenital heart defects (CHDs) are present in about 40-60% of newborns with Down syndrome (DS). Patients with DS can also develop acquired cardiac disorders. Mouse models suggest that a critical 3.7 Mb region located on human chromosome 21 (HSA21) could explain the association with CHDs. This region includes a cluster of genes (IFNAR1, IFNAR2, IFNGR2, IL10RB) encoding for interferon receptors (IFN-Rs). Other genes located on different chromosomes, such as the vascular endothelial growth factor A (VEGFA), have been shown to be involved in cardiac defects. So, we investigated the association between single nucleotide polymorphisms (SNPs) in IFNAR2, IFNGR2, IL10RB and VEGFA genes, and the presence of CHDs or acquired cardiac defects in patients with DS.

Methods: Individuals (n = 102) with DS, and age- and gender-matched controls (n = 96), were genotyped for four SNPs (rs2229207, rs2834213, rs2834167 and rs3025039) using KASPar assays.

Results: We found that the IFNGR2 rs2834213 G homozygous genotype and IL10RB rs2834167G-positive genotypes were more common in patients with DSand significantly associated with heart disorders, while VEGFA rs3025039T-positive genotypes (T/*) were less prevalent in patients with CHDs.

Conclusions: We identified some candidate risk SNPs for CHDs and acquired heart defects in DS. Our data suggest that a complex architecture of risk alleles with interplay effects may contribute to the high variability of DS phenotypes.

Keywords: Down syndrome; IFNR; SNPs; VEGFA; heart defects.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Gensous N., Bacalini M.G., Franceschi C., Garagnani P. Down syndrome, accelerated aging and immunosenescence. Semin. Immunopathol. 2020;42:635–645. doi: 10.1007/s00281-020-00804-1. - DOI - PMC - PubMed
    1. Van der Linde D., Konings E.E., Slager M.A., Witsenburg M., Helbing W.A., Takkenberg J.J., Roos-Hesselink J.W. Birth prevalence of congenital heart disease worldwide: A systematic review and meta-analysis. J. Am. Coll. Cardiol. 2011;58:2241–2247. doi: 10.1016/j.jacc.2011.08.025. - DOI - PubMed
    1. Khoury M.J., Erickson J.D. Improved ascertainment of cardiovascular malformations in infants with Down’s syndrome, Atlanta, 1968 through 1989. Implications for the interpretationof increasing rates of cardiovascular malformationsin surveillance systems. Am. J. Epidemiol. 1992;136:1457–1464. doi: 10.1093/oxfordjournals.aje.a116466. - DOI - PubMed
    1. Irving C.A., Chaudhari M.P. Cardiovascular abnormalities in Down’s syndrome: Spectrum, management and survival over 22 years. Arch. Dis. Child. 2012;97:326–330. doi: 10.1136/adc.2010.210534. - DOI - PubMed
    1. Santoro M., Coi A., Spadoni I., Bianchi F., Pierini A. Sex differences for major congenital heart defects in Down Syndrome: A population based study. Eur. J. Med. Genet. 2018;61:546–550. doi: 10.1016/j.ejmg.2018.05.013. - DOI - PubMed

Publication types

Substances